|
FY2025
12 months to Jan 2, 2026
|
FY2024
12 months to Jan 3, 2025
|
FY2023
12 months to Dec 29, 2023
|
FY2022
12 months to Dec 30, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Goodwill impairment | |||||
| Sales and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Amortization of purchased intangibles | |||||
| Intangible and long-lived asset impairment | |||||
| Total operating expenses | |||||
| (Loss) income from operations | |||||
| Interest expense | |||||
| Other (income) expense, net | |||||
| Interest and other expense, net | |||||
| (Loss) income before income taxes | |||||
| Income Tax Expense (Benefit) | |||||
| Net (loss) income | |||||
| Less: net loss attributable to non-controlling interest | |||||
| Net (loss) income attributable to Fox stockholders | |||||
| (Net loss) earnings per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares used to compute earnings per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...